Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.97%30.05B | -9.70%21.05B | -15.92%11.92B | -10.45%44.26B | -10.13%33.01B | -8.34%23.31B | -2.60%14.17B | 1.70%49.43B | 1.50%36.73B | 6.65%25.43B |
| Refunds of taxes and levies | 23.37%27.44M | 120.88%25.46M | 298.75%24.97M | -51.68%26.43M | -50.74%22.24M | -71.58%11.53M | 18.85%6.26M | -86.83%54.71M | -87.65%45.15M | -32.69%40.56M |
| Cash received relating to other operating activities | -20.06%1.36B | -15.54%1.08B | 20.99%535.51M | 17.82%1.71B | 59.89%1.7B | 82.35%1.28B | -73.78%442.61M | 8.09%1.45B | 19.40%1.06B | 43.95%702.09M |
| Cash inflows from operating activities | -9.49%31.43B | -9.94%22.16B | -14.66%12.48B | -9.69%45.99B | -8.21%34.73B | -6.00%24.6B | -9.99%14.62B | 1.14%50.93B | 1.06%37.83B | 7.30%26.18B |
| Goods services cash paid | -2.27%26.61B | -2.24%18.74B | -3.04%10.98B | -8.96%35.57B | -5.60%27.23B | -3.46%19.17B | 1.82%11.33B | -0.14%39.08B | 1.80%28.84B | 7.45%19.86B |
| Staff behalf paid | -8.20%1.95B | -6.93%1.42B | -6.15%861.27M | -9.62%2.8B | -7.81%2.12B | -8.93%1.52B | -8.42%917.67M | -1.73%3.1B | -2.99%2.3B | -0.94%1.67B |
| All taxes paid | -17.75%882.44M | -15.94%677.27M | -2.77%400.37M | -11.50%1.38B | -9.47%1.07B | -13.08%805.72M | -12.46%411.78M | 15.46%1.56B | 15.55%1.19B | 12.83%927.01M |
| Cash paid relating to other operating activities | -14.55%2.23B | -10.75%1.69B | -30.71%756.42M | -21.25%2.81B | -4.11%2.61B | 3.80%1.89B | 50.79%1.09B | 7.61%3.57B | -3.12%2.72B | 1.76%1.82B |
| Cash outflows from operating activities | -4.12%31.67B | -3.71%22.52B | -5.43%13B | -10.02%42.57B | -5.76%33.03B | -3.66%23.39B | 3.21%13.75B | 0.75%47.31B | 1.48%35.05B | 6.57%24.28B |
| Net cash flows from operating activities | -114.22%-240.61M | -129.81%-362.68M | -159.67%-522.1M | -5.46%3.42B | -39.14%1.69B | -35.93%1.22B | -70.09%875.03M | 6.46%3.62B | -4.01%2.78B | 17.46%1.9B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 31.39%1.61B | -2.13%845.51M | -69.82%213.95M | 159.50%2.37B | 104.28%1.23B | 168.68%863.91M | 124.85%708.98M | 49.77%915.17M | 23.16%600.71M | -31.24%321.54M |
| Cash received from returns on investments | 101.60%188.09M | 137.50%66.12M | --23.83M | 29.83%113.66M | 8.40%93.3M | 128,164.41%27.84M | ---- | -39.59%87.54M | -35.89%86.07M | -99.86%21.7K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 26,114.87%1.02B | -42.18%1.45M | 94.80%1.14M | -51.48%5.42M | -54.12%3.89M | -56.78%2.51M | -74.96%585.04K | -81.98%11.17M | -84.24%8.49M | -89.05%5.81M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --1.89B | --2.18B | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | --1.02M | --1.02M | ---- | -1.46%2.67M | ---- | ---- | ---- | 88.97%2.71M | ---- | ---- |
| Cash inflows from investing activities | -19.47%2.82B | 2.22%914.1M | -66.33%238.92M | 331.28%4.38B | 404.09%3.5B | 173.17%894.26M | 123.38%709.57M | -62.72%1.02B | 1.35%695.26M | -40.12%327.37M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 15.18%903.16M | 74.66%595.75M | 3.95%226.62M | -10.27%1.01B | 13.37%784.14M | -31.84%341.09M | -18.04%218.01M | 23.29%1.13B | 13.37%691.68M | 18.87%500.42M |
| Cash paid to acquire investments | -12.84%2.25B | -43.92%675.05M | -63.84%381.08M | 198.25%3.91B | 453.81%2.58B | 626.92%1.2B | 6,655.00%1.05B | 7.69%1.31B | -4.15%465.6M | -38.27%165.6M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -92.59%743K | -92.59%743K | -54.11%743K |
| Cash outflows from investing activities | -6.31%3.15B | -17.74%1.27B | -52.22%607.7M | 101.82%4.92B | 190.38%3.36B | 131.70%1.54B | 350.44%1.27B | 9.99%2.44B | 4.72%1.16B | -3.49%666.77M |
| Net cash flows from investing activities | -331.07%-328.24M | 45.17%-356.71M | 34.41%-368.78M | 62.30%-535.78M | 130.70%142.05M | -91.69%-650.6M | -1,692.71%-562.23M | -378.63%-1.42B | -10.22%-462.76M | -135.40%-339.4M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 2,456.29%447.35M | --367.35M | --367.35M | -89.16%17.5M | -89.16%17.5M | ---- | ---- | 437.93%161.38M | --161.38M | --145.8M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 2,456.29%447.35M | --367.35M | --367.35M | -89.16%17.5M | -89.16%17.5M | ---- | ---- | 437.93%161.38M | --161.38M | --145.8M |
| Cash from borrowing | -5.93%8.13B | -13.79%4.73B | -13.63%2.66B | 54.35%9.35B | 81.01%8.64B | 32.16%5.49B | 799.14%3.08B | -25.18%6.06B | -34.54%4.78B | 40.75%4.15B |
| Cash received relating to other financing activities | ---- | ---- | ---- | --29.77M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -0.95%8.58B | -7.10%5.1B | -1.69%3.02B | 51.11%9.4B | 75.45%8.66B | 27.68%5.49B | 799.14%3.08B | -23.47%6.22B | -32.33%4.94B | 45.69%4.3B |
| Borrowing repayment | -6.66%7.54B | 1.91%4.93B | -0.60%3.07B | 66.55%10B | 78.80%8.08B | 26.45%4.84B | 435.65%3.09B | -6.59%6.01B | -22.01%4.52B | 23.69%3.82B |
| Dividend interest payment | 44.90%739.03M | -25.31%139.56M | -39.89%48.67M | 17.29%602.98M | 35.38%510.02M | 69.99%186.85M | 116.53%80.97M | -25.60%514.1M | -37.84%376.73M | -61.87%109.92M |
| -Including:Cash payments for dividends or profit to minority shareholders | -9.64%128.12M | -91.35%8.12M | -89.95%1.78M | -10.42%126.83M | 315.58%141.78M | 808.66%93.89M | 120.55%17.75M | -43.13%141.59M | -82.66%34.12M | -94.75%10.33M |
| Cash payments relating to other financing activities | -18.76%908.24M | -22.88%580.18M | -34.57%268.99M | -9.89%1.63B | -9.63%1.12B | -8.43%752.28M | -1.16%411.1M | 8.29%1.81B | 15.02%1.24B | 39.54%821.52M |
| Cash outflows from financing activities | -5.35%9.19B | -2.20%5.65B | -5.39%3.39B | 46.87%12.24B | 58.29%9.71B | 21.43%5.77B | 247.72%3.58B | -5.25%8.34B | -17.96%6.13B | 19.83%4.76B |
| Net cash flows from financing activities | 41.82%-607.41M | -92.32%-547.27M | 27.83%-365.91M | -34.42%-2.84B | 12.62%-1.04B | 37.53%-284.57M | 26.32%-507.04M | -215.55%-2.12B | -568.89%-1.19B | 55.21%-455.56M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 2.74%-265.21K | -383.63%-170.89K | 16.97%-23.98K | 1,929.96%188K | -39.31%-272.68K | 81.21%-35.34K | -122.34%-28.88K | 97.71%-10.27K | 52.59%-195.73K | -39.22%-188.03K |
| Net increase in cash and cash equivalents | -248.93%-1.18B | -550.13%-1.27B | -546.96%-1.26B | -47.68%44.58M | -29.64%789.96M | -74.50%281.43M | -108.55%-194.27M | -97.37%85.22M | -51.14%1.12B | 142.47%1.1B |
| Add:Begin period cash and cash equivalents | 0.26%16.99B | 0.26%16.99B | 0.26%16.99B | 0.51%16.94B | 0.51%16.94B | 0.51%16.94B | 0.51%16.94B | 23.81%16.86B | 23.96%16.86B | 23.96%16.86B |
| End period cash equivalent | -10.84%15.81B | -8.73%15.72B | -6.08%15.73B | 0.26%16.99B | -1.38%17.73B | -4.10%17.22B | -12.45%16.75B | 0.51%16.94B | 13.11%17.98B | 27.80%17.96B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.